the inhibitory effect of sulforaphane on the proliferation of acute myeloid leukemia cell lines through controlling mir-181a

Objective: the present study investigated the role of mir-181a as a small non-coding rna molecule in acute myeloid leukemia (aml) pathogenesis and reflected on the effects of sulforaphane (sfn) on aml progression. materials and methods: this experimental study had two parts. in vivo study, the mir-181a levels was measured in patients with symptoms of aml and compared to healthy controls (hcs) to investigate its role in aml pathogenesis. afterward, an in vitro study was performed to examine the effects of sfn on the growth, apoptosis and proliferation rate of aml cell lines. finally, the effect of sfn on mir-181a was evaluated as a major mirna involved in hematopoiesis. results: the results of this study showed an increasing trend (2.9-fold, p=0.0019) in mir-181a expression levels in aml patients as compared with hcs. the data associated with mtt assay and flow cytometry (fcm) additionally demonstrated the anti-proliferative effects of sfn against aml cell lines, with a reduction in mir-181a levels. as well, no significant difference was noted between 24 hours and 48 hours treatments by sfn. it was deduced that modulation of mir-181a expression levels could be one of the mechanisms associated with the anti-proliferative effects of sfn against aml. conclusion: mir-181a levels contribute to aml pathogenesis and thus they can be considered as a strategy in controlling aml progression in patients. accordingly, sfn can arrest cell proliferation and induce apoptosis in aml cell lines through retardation expression of mir-181a and affecting mir-181a pathway, which already clarified its role in the differentiation of hematopoietic stem cells and indicates another mode of anti-cancer action of sulforaphane